Danazol as First-Line Therapy for Myelodysplastic Syndrome

Perla R. Colunga‐Pedraza, Julia E. Colunga‐Pedraza, María Alejandra Garza-Ledezma, José Carlos Jaime‐Pérez, Olga Graciela Cantú‐Rodríguez, Cesar Homero Gutiérrez‐Aguirre, Erick Joel Rendón-Ramírez, Yadith Karina López‐García, Rosa Elena Lozano-Morales, Andrés Gómez‐De León, Guillermo Sotomayor‐Duque, David Gómez‐Almaguer
In: Clinical Lymphoma Myeloma and Leukemia · 2017 · vol. 18(2) , pp. e109–e113 · doi:10.1016/j.clml.2017.11.007 · PMID:29268959 · W2769076648
article OA: closed CC0 ⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (42)

Cited by (8)

Source provenance

openalex
last seen: 2026-05-11T05:58:56.137231+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0 · commercial use OK